| Medical Condition | Progressive Pulmonary Fibrosis (ILD) |
| Facility/Clinic | Accellacare – 1222 Medical Center Dr |
| Age | 21+ |
| Gender | Male & Female |
| Description | A study to measure the safety and efficacy of two different dosages of study medication versus placebo to treat Progressive Pulmonary Fibrosis |
| Enrollment | Open |
| Patient Commitment Duration | minimum of 14 months – up to 4 years |
| Number of visits in study | 14+ visits |
| Patient Compensation | $100/visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.